A Preview Of Macrogenics's Earnings
Portfolio Pulse from Benzinga Insights
Macrogenics (NASDAQ:MGNX) is expected to report a Q4 earnings per share (EPS) of $-0.15 on March 7, 2024. Analysts and investors are hopeful for a beat on this estimate and positive guidance for the next quarter. The company's past earnings performance shows a pattern of beating EPS estimates, leading to significant share price increases. Shares are currently trading at $20.64, with a 245.06% increase over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.
March 06, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Macrogenics is anticipated to report a Q4 EPS of $-0.15, with investors looking for a beat and positive future guidance. The stock has seen a 245.06% increase over the past year, indicating strong investor confidence.
Given Macrogenics's history of beating EPS estimates and the subsequent positive impact on its stock price, there is a high likelihood of a positive short-term impact on MGNX's stock price if the company reports a beat and provides optimistic guidance. The historical data shows a clear correlation between earnings performance and stock price movement, suggesting a similar outcome could be expected.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100